The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

ConditionsVelocardiofacial Syndrome Williams Syndrome Fragile X Syndrome

Trial statusRecruiting

Trial phasePhase 4

Trial typeInterventional

Biological sexAll

AgeNot listed

SponsorThe Chaim Sheba Medical Center

About this trial

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

chromosomal deletion proven by FISH examination

Disqualifiers

None

Trial design

Design model

Single group

Treatments tested in this trial

methylphenidate, fluoxetin, risperidone
Drug
first cognitive evaluation without methylphenidate,second cognitive evaluation with methylphenidate

Treatment groups

400 Participants

are divided into 1 treatment group

Group A: 1Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

Measure that are used: psychological measures, molecular tests, responsiveness to medical treatments

Time frame

2 years

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

The Chaim Sheba Medical Center

Lead sponsor

Source ClinicalTrials.gov

Apply now